Clinical Trial Update: Natural History of Autosomal Dominant Optic Atrophy (ADOA), Caused by OPA1 Mutation

View source ↗

Summary

Status update on a natural history study of Autosomal Dominant Optic Atrophy due to OPA1 mutation; the trial is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Optic Atrophy
• Kjer Optic Atrophy
• Optic Atrophy

Snippet

Sponsor: PYC Therapeutics | Conditions: Autosomal Dominant Optic Atrophy, Optic Atrophy, Autosomal Dominant | Status: TERMINATED